Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,0767,13-0,71
Msft-1,84
Nokia3,11053,2692,05
IBM-0,89
Mercedes-Benz Group AG75,0675,080,55
PFE-0,12
19.04.2024 8:00:02
Indexy online
AD Index online
select
AD Index online
 

  • 04.04.2024 11:25:32
Getinge AB (GIND.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
18,23 -3,00 -0,55 9 498
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.04.2024
Popis společnosti
Obecné informace
Název společnostiGetinge AB
TickerGETI B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICGETIb.ST
ISINSE0000202624
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 11 739
Akcie v oběhu k 31.12.2023 272 369 573
MěnaSEK
Kontaktní informace
UliceLindholmspiren 7,
MěstoGOETEBORG
PSČ417 56
ZeměSweden
Kontatní osobaLars Mattsson
Funkce kontaktní osobyHead - Investor Relations
Telefon4 635 155 500
Fax468295532
Kontatní telefon46 103 350 043

Business Summary: Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Getinge AB revenues increased 12% to SEK31.83B. Net income decreased 3% to SEK2.41B. Revenues reflect Surgical Workflows segment increase of 22% to SEK10.97B, Acute Care Therapies segment increase of 8% to SEK16.53B, Life Science segment increase of 7% to SEK4.33B, Americas segment increase of 15% to SEK13.15B, EMEA segment increase of 16% to SEK11.11B, APAC segment increase of 4% to SEK6.94B.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSAdministrative Management and General Management Consulting Services
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Admin & Gen Management Consulting Services
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Administrative Management and General Management Consulting Services
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICManagement Consulting Services



  • Poslední aktualizace: 19.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorMattias Perjos5129.03.201727.03.2017
Vice Chairman of the BoardCarl Bennet7323.04.201901.01.1997
Chief Financial OfficerAgneta Palmer4531.03.202415.09.2022
President - Acute Care TherapiesElin Frostehav4101.04.202201.04.2022
President - Life ScienceEric Honroth5201.04.202201.04.2022
President - Surgical WorkflowsStephane Le Roy4612.11.201812.11.2018
Executive Vice President - Human Resources and SustainabilityMagnus Lundbaeck5401.01.2008
Executive Vice President - Quality Compliance, Regulatory and Medical AffairsJoanna Engelke6306.10.202206.10.2022
Executive Vice President - Legal, Compliance and GovernanceAnna Romberg4416.09.202016.09.2020
Chief Commercial OfficerCarsten Blecker5701.01.2016